Administration is simple with two doses during the dry-off period.
The acquisition is part of its broader strategy to expand across Europe and diversify its portfolio.
EFSA said these intake values reflect the higher end of typical consumption, ensuring the assessment remains precautionary.
This translates into total growth of 50.6%, with demand forecast to expand at a compound annual growth rate (CAGR) of 4.2% between 2025 and 2035.
The market is projected to expand significantly by 2028